These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15908727)

  • 21. Drug therapy for termination of atrial fibrillation and maintenance of sinus rhythm.
    Talajic M; Roy D
    Can J Cardiol; 2005 Sep; 21 Suppl B():19B-25B. PubMed ID: 16239983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mending the rhythm does not improve prognosis in patients with persistent atrial fibrillation: a subanalysis of the RACE study.
    Rienstra M; Van Gelder IC; Hagens VE; Veeger NJ; Van Veldhuisen DJ; Crijns HJ
    Eur Heart J; 2006 Feb; 27(3):357-64. PubMed ID: 16275661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restoration of sinus rhythm in patients with atrial fibrillation.
    Talajic M; MacDonald RG; Nattel S
    Can J Cardiol; 1996 Jan; 12 Suppl A():29A-35A. PubMed ID: 8597999
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of pacemaker and defibrillator therapy for the treatment of atrial fibrillation.
    Mitchell AR
    Minerva Cardioangiol; 2004 Apr; 52(2):141-53. PubMed ID: 15194995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation by non-deterministic modelling.
    Zohar P; Kovacic M; Brezocnik M; Podbregar M
    Europace; 2005 Sep; 7(5):500-7. PubMed ID: 16087117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
    Hemels ME; Van Noord T; Crijns HJ; Van Veldhuisen DJ; Veeger NJ; Bosker HA; Wiesfeld AC; Van den Berg MP; Ranchor AV; Van Gelder IC
    J Am Coll Cardiol; 2006 Sep; 48(5):1001-9. PubMed ID: 16949494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome parameters for trials in atrial fibrillation: executive summary.
    Kirchhof P; Auricchio A; Bax J; Crijns H; Camm J; Diener HC; Goette A; Hindricks G; Hohnloser S; Kappenberger L; Kuck KH; Lip GY; Olsson B; Meinertz T; Priori S; Ravens U; Steinbeck G; Svernhage E; Tijssen J; Vincent A; Breithardt G
    Eur Heart J; 2007 Nov; 28(22):2803-17. PubMed ID: 17897924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial fibrillation.
    Campbell RW
    Eur Heart J; 1998 May; 19 Suppl E():E41-5, E60-3. PubMed ID: 9717024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].
    Niu F; Huang CX; Jiang H; Yang B; Guo WL; Chen YX; Jin CR; Liu ZM
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):121-3. PubMed ID: 16620720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Curtis AB; Gersh BJ; Corley SD; DiMarco JP; Domanski MJ; Geller N; Greene HL; Kellen JC; Mickel M; Nelson JD; Rosenberg Y; Schron E; Shemanski L; Waldo AL; Wyse DG;
    Am Heart J; 2005 Apr; 149(4):645-9. PubMed ID: 15990747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardioversion for atrial fibrillation: treatment options and advances.
    Reiffel JA
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):1073-84. PubMed ID: 19659629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Predictive factors of maintenance of sinus rhythm after direct current (DC) cardioversion of atrial fibrillation/atrial flutter].
    Larsen MT; Lyngborg K; Pedersen F; Corell P
    Ugeskr Laeger; 2005 Sep; 167(36):3408-12. PubMed ID: 16159494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential recovery of regional atrial contraction after restoration of sinus rhythm after intraoperative linear radiofrequency ablation for atrial fibrillation.
    Boyd AC; Schiller NB; Ross DL; Thomas L
    Am J Cardiol; 2009 Feb; 103(4):528-34. PubMed ID: 19195515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial fibrillation: insights from clinical trials and novel treatment options.
    Blaauw Y; Crijns HJ
    J Intern Med; 2007 Dec; 262(6):593-614. PubMed ID: 18028181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrical and pharmacologic cardioversion for atrial fibrillation.
    Kim SS; Knight BP
    Med Clin North Am; 2008 Jan; 92(1):101-20, xi. PubMed ID: 18061000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrial fibrillation: rate versus rhythm control.
    Amani F; Smith ES
    J Ark Med Soc; 2005 Oct; 102(4):110-2. PubMed ID: 16265929
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacologic approaches to rhythm versus rate control in atrial fibrillation--where are we now?
    Wyse DG
    Int J Cardiol; 2006 Jun; 110(3):301-12. PubMed ID: 16516313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent atrial fibrillation as a prognostic factor of outcome in patients with advanced heart failure.
    Wojtkowska I; Sobkowicz B; Musiał WJ; Kozuch M
    Kardiol Pol; 2006 Aug; 64(8):777-83; discussion 784-5. PubMed ID: 16981052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure.
    Hoppe UC; Casares JM; Eiskjaer H; Hagemann A; Cleland JG; Freemantle N; Erdmann E
    Circulation; 2006 Jul; 114(1):18-25. PubMed ID: 16801461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-year outcome of cardioversion of atrial fibrillation in patients with mitral stenosis after percutaneous balloon mitral valvuloplasty.
    Krittayaphong R; Chotinaiwatarakul C; Phankingthongkum R; Panchavinnin P; Tresukosol D; Jakrapanichakul D; Sriratanasathavorn C; Kitrattana B; Kangkagate C
    Am J Cardiol; 2006 Apr; 97(7):1045-50. PubMed ID: 16563913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.